ENTITY

Cellid (299660 KS)

23
Analysis
Health Care • South Korea
Cellid, Co., Ltd. develops biotechnology. The Company develops innovative immunotherapeutic vaccines, immunology and molecular biology technology, and other related products. Cellid also manufactures and distributes pharmaceuticals and functional foods.
more
Exchange Announcement • 21 Sep 2026 19:21

Contract of Shares Acquisition and Assignment concerning the Change of Control

Exchange Announcement • 21 Sep 2026 17:56

Resolutions for Convocation of General Meeting of Shareholders(임시주주총회)

Exchange Announcement • 14 Aug 2026 15:39

Settlement of Lawsuit (Charging More Than Certain Amount)

Exchange Announcement • 13 Aug 2026 13:15

[Revised] Material Management Information related to Judgment of Investment(ì‚¬ì— ë°˜í™˜ì²­êµ¬ì˜ 소 ì œê¸°ì˜ ê±´)

Exchange Announcement • 06 Aug 2026 16:33

[Revised] Lawsuit (Charging More Than Certain Amount)

x